drugset / Trial / NCT03026478

Topical Betamethasone and Clobetasol in Orabase in Oral Lichen Planus

NCT03026478

Phase 2 Unknown 30 enrolled Garlapati Komali
RandomizedParallel-groupSingle-blindTreatment

Summary

Oral Lichen Planus (OLP) is an autoimmune, chronic inflammatory mucocutaneous disease characterized by pain and burning sensation. The major types of OLP are the following: reticular, atrophic, erosive-ulcerative, bullous and pigmentous form.Its etiology remains unclear. The presence of auto-cytotoxic T cell clones in the lesions suggests the role of autoimmunity. Numerous treatment options of OLP include topical and systemic agents depending on severity of lesions . Topical corticosteroids abide the mainstay of therapy,and are widely accepted as the primary treatment of choice.Hence this study is designed to evaluate and compare the clinical efficacy of topical Clobetasol 0.05% in orabase and Betamethasone 0.05% in orabase in combination with Clotrimazole 1% in the management of symptomatic Oral Lichen Planus.

Timeline

Start
2016-05-06
Primary completion
2018-03
Completion
2018-06

Drugs

EvaluationDrugModalityDoseRoute
Subject betamethasone dipropionate Small molecule 0.05 % Topical
Comparator clobetasol propionate Small molecule 0.05 % Topical

Indications